News

With approval Ruzurgi becomes first treatment for LEMS approved for children.

A recent study found that black patients were far less likely to be prescribed buprenorphine than white patients.

Both parents and children with atopic dermatitis often lack answers when it comes to the possibility that food allergies might be causing their skin irritations.

Patients who experienced hypertensive disorders in pregnancy were 80% more likely to develop choroidal neovascular AMD at an early age.

An early-start treat-and-extend regimen produced comparable efficacy with fewer aflibercept injections than regular injections every 8 weeks.

Findings from ASCENT-COPD show the long-acting muscarinic antagonist is noninferior to placebo in driving major adverse cardiovascular event risk in very at-risk patients with COPD.

New data from PARTNER 3 shows the procedure reduces one-year mortality in patients with aortic stenosis.

Telehealth and technology have broadened the capabilities of surgeons.

Tafamidis and tafamidis meglumine reported a greater survival rate in treated patients than those administered placebo, and reported a reduced rate of hospitalizations from cardiovascular problems.

Research has shown that few children with asthma correctly use their inhalers, despite guidelines explicitly stating that each physician visit should include review of inhaler technique and use of devices.

In a study that builds upon the hypothesis, researchers say early-in-life health factors can have an impact on adults’ health.

The SmartSync includes a mobile application, telemetry head, and pacing system analyzer that allows for direct patient-to-physician data sharing.

The GSK triple-combination FF/UMEC/VI inhaler reported significant lung function improvement in patients with inadequately controlled asthma.

A new meta analysis speculates whether specialists or primary care physicians are the best clinicians to diagnose, treat, and manage COPD.

The tropical-based virus is prevalent in areas inhabited by about one-third of the world's population.

The lot is being voluntarily recalled due to a detected microbial growth during a routine manufacturing simulation—indicating a potential introduction of microorganisms into the therapy.

How wearable devices and their massive patient pools have created a balancing act between mass patient arrhythmia data collection and individualized care.

Marketed sunscreen in the US is a bit more regulated than in other countries. But are those regulations helpful?

A major clinical challenge encountered by thoracic surgeons lies in the decision to pursue surgery, which must be weighed between surgical risk and the reliability of CT findings.

Some programs are governed by medical or radiation oncology departments, whereas others are led by pulmonology, radiology, pathology, or thoracic surgery departments, often in multidisciplinary combinations.

Most programs offer smoking cessation counseling as part of the shared decision making visit and throughout the program. Some LCS programs also order pulmonary function studies for new patients to provide an overall picture of lung health.

Patient management software programs have been developed to help track patients in LCS programs. These programs can automatically generate reminders for patients in the form of letters and phone calls.

To confirm that LCS programs abide by the American College of Radiology and Society of Thoracic Radiology specifications, screening should follow a standardized and structured protocol.

Most LCS programs have systems in place to ensure compliance with the eligibility criteria before an exam is scheduled and a scan is performed.

Regardless of the type of program structure, most experts agree that a program coordinator is critical for developing a successful program.

Hybrid lung cancer screening programs use a combination of centralized and decentralized services.

LCS programs must be integrated with a smoking cessation program, and data should be collected regarding the interventions offered to active smokers.

In a 47-patient study, all who received the therapy for either 8 or 16 weeks had no detected virus in their blood samples post-12 weeks, indicating cured infection.